Stephen F. Mahoney
2020
In 2020, Stephen F. Mahoney earned a total compensation of $2M as Chief Financial and Operating Officer at Dianthus Therapeutics.
Compensation breakdown
Option Awards | $1,888,655 |
---|---|
Salary | $70,000 |
Other | $475 |
Total | $1,959,130 |
Mahoney received $1.9M in option awards, accounting for 96% of the total pay in 2020.
Mahoney also received $70K in salary and $475 in other compensation.
Rankings
In 2020, Stephen F. Mahoney's compensation ranked 5,608th out of 13,090 executives tracked by ExecPay. In other words, Mahoney earned more than 57.2% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 5,608 out of 13,090 | 57th |
Division Manufacturing | 2,315 out of 5,624 | 59th |
Major group Chemicals And Allied Products | 925 out of 2,257 | 59th |
Industry group Drugs | 800 out of 1,957 | 59th |
Industry Pharmaceutical Preparations | 595 out of 1,462 | 59th |
Source: SEC filing on April 21, 2021.
Mahoney's colleagues
We found two more compensation records of executives who worked with Stephen F. Mahoney at Dianthus Therapeutics in 2020.